Investor Presentaiton slide image

Investor Presentaiton

HKAS 1.51(a) HKAS 1.49 HK Listco Ltd Financial statements for the year ended 31 December 2023 (iii) Movements in the present value of the defined benefit obligation HKAS 19.140(a)(ii) At 1 January: HKAS 19.141(c)(ii) HKAS 19.141(c)(iii) Remeasurements: Actuarial losses arising from changes in demographic assumptions 239 Actuarial losses arising from changes in financial assumptions HKAS 19.141(g) Benefits paid by the plans HKAS 19.141(a) Current service cost HKAS 19.141(b) Interest cost At 31 December 2023 2022 $'000 $'000 108,298 94,290 35 18 13 24 48 42 (5,976) (5,500) 13,834 13,286 6,793 6,180 122,997 108,298 HKAS 19.147(c) The weighted average duration of the defined benefit obligation is [ years (2022: years). HKAS 19.140(a)(i) (iv) Movements in plan assets At 1 January: HKAS 19.141(f) Group's contributions paid to the plans 240 HKAS 19.141(g) Benefits paid by the plans HKAS 19.141(b) Interest income HKAS 19.141(c)(i) Return on plan assets, excluding interest income At 31 December HKAS 19.145 and 173(b) (v) 2023 2022 $'000 $'000 106,596 93,086 14,579 13,720 (5,976) (5,500) 5,750 5,250 51 40 121,000 106,596 Amounts recognised in the consolidated statement of profit or loss and other comprehensive income are as follows: Current service cost Net interest on net defined benefit liability 241 Total amounts recognised in profit or loss 2023 2022 $'000 $'000 13,834 13,286 1,043 930 14,877 14,216 Actuarial losses 48 42 Return on plan assets, excluding interest income (51) (40) Total amounts recognised in other comprehensive income (3) 2 Total defined benefit costs 14,874 14,218 243 Entities are required to disclose a sensitivity analysis for significant actuarial assumptions. In accordance with paragraph 145 of HKAS 19, an entity should disclose: a sensitivity analysis for each significant actuarial assumption as disclosed under paragraph 144 of HKAS 19 as of the end of the reporting period, showing how the defined benefit obligation would have been affected by changes in the relevant actuarial assumption that were reasonably possible at that date; the methods and assumptions used in preparing the sensitivity analyses and the limitations of those methods; and changes from the previous period in the methods and assumptions used in preparing the sensitivity analyses, and the reasons for such changes. 151 © 2023 KPMG, a Hong Kong partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited ("KPMG International"), a private English company limited by guarantee. All rights reserved.
View entire presentation